Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 2131 AL 2145

Bilingualism for delaying the onset of Alzheimer's disease: a systematic review and meta-analysis

Paulavicius AM, Mizzaci CC, Tavares DRB, Rocha AP, Civile VT, Schultz RR, Pinto ACPN, Trevisani VFM.

Eur Geriatr Med. 2020 Aug;11(4):651-658. doi: 10.1007/s41999-020-00326-x. Epub 2020 May 4.

The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study

Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger Å, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7.

Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease

Isaia G, Marinello R, Tibaldi V, Tamone C, Bo M.

Am J Geriatr Psychiatry. 2020 Jul;28(7):790-791. doi: 10.1016/j.jagp.2020.04.018. Epub 2020 Apr 22.

Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease

de Freitas GB, Lourenco MV, De Felice FG.

J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2.

Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery

Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S; Alzheimer Precision Medicine Initiative.

Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.

Convolutional neural networks for classification of Alzheimer's disease: Overview and reproducible evaluation

Wen J, Thibeau-Sutre E, Diaz-Melo M, Samper-González J, Routier A, Bottani S, Dormont D, Durrleman S, Burgos N, Colliot O; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing.

Med Image Anal. 2020 Jul;63:101694. doi: 10.1016/j.media.2020.101694. Epub 2020 May 1.

Empathy and Theory of Mind in Alzheimer's Disease: A Meta-analysis

Demichelis OP, Coundouris SP, Grainger SA, Henry JD.

J Int Neuropsychol Soc. 2020 Nov;26(10):963-977. doi: 10.1017/S1355617720000478. Epub 2020 May 20.

Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate

van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.

Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.

Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial

Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.

JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.

APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset

Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan ME, Breitner J; PREVENT-AD Research Group; Rajah MN.

J Alzheimers Dis. 2020;76(1):97-119. doi: 10.3233/JAD-191292.

Evidence on the New Drug Lumateperone (ITI-007) for Psychiatric and Neurological Disorders

Mazza M, Marano G, Traversi G, Sani G, Janiri L.

CNS Neurol Disord Drug Targets. 2020;19(4):243-247. doi: 10.2174/1871527319666200601145653.

The impact of tamsulosin on cognition in Alzheimer disease with benign prostate hyperplasia: A study using the Hallym Smart Clinical Data Warehouse

Sohn JH, Lee SH, Kwon YS, Kim JH, Kim Y, Lee JJ.

Medicine (Baltimore). 2020 May 29;99(22):e20240. doi: 10.1097/MD.0000000000020240.

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data

Sekine T, Buck A, Delso G, Kemp B, Ter Voert EEGW, Huellner M, Veit-Haibach P, Kaushik S, Wiesinger F, Warnock G; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2020 Jun 3;15(6):e0233886. doi: 10.1371/journal.pone.0233886. eCollection 2020.

The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial

Park KS, Ganesh AB, Berry NT, Mobley YP, Karper WB, Labban JD, Wahlheim CN, Williams TM, Wideman L, Etnier JL.

BMC Neurol. 2020 Jun 6;20(1):231. doi: 10.1186/s12883-020-01732-1.

Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial

Traini E, Carotenuto A, Fasanaro AM, Amenta F.

J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias